Patent applications status Q3-Q4 2023

The first patent application on the basic concept of PexyEazy® is accepted in USA, Japan, Singapore, Russia, South Africa, Israel and China. The international patent applications in Canada, Brazil, EU, India and Australia are still pending. International patent application based on the second patent is also filed in Canada, USA, Brazil, EU, South Africa, Russia, […]

First PexyEazy® procedure on human

First PexyEazy® procedure on human, as the first patient participated in the SCI-Pex study, a safety and feasibility study on PexyEazy®. A total of 35 patients will be included in the SCI-Pex study at two sites in Sweden.

EIC Seal of Excellence

Developeration AB was awarded “Seal of Excellence” by the European Commission as part of the application for Horizon EIC 2022 Accelerator grant. Our application was scored as a high-quality project proposal in a highly competitive evaluation process. We were invited for interviews this time, but unfortunately did we not get the grant.

Second investment round

ALMI Invest, STOAF, Rentability AB, Adiuvero AB and GAEU Venture AB invest I Developeration AB’s second investment round, in total 11,5 MSEK.

Best Medical Devices Developer – Scandinavia

Developeration has been acknowledged as the “Best Medical Devices Developer – Scandinavia” by GHP, Global Health and Pharmacy, a global information sharing platform. https://www.ghp-news.com/winners-list/?award=11481-2021

Gold company

Developeration AB is accepted to the EIT Health Investor Network as a GOLD Company.

Most innovative medical devices developer

Developeration has been acknowledged as the “Most innovative medical devices developer – Scandinavia” by GHP, Global Health and Pharmacy, a global information sharing platform. https://www.ghp-news.com/winners/developeration-ab/

4.4MSEK invested in Developeration

2020-09-15 ALMI Invest and STOAF, invest in Developeration AB, in total 4,4MSEK. https://stoaf.se/2020/09/15/stoaf-invests-in-developerations-innovative-surgical-device/